JRCT ID: jRCT1080222794
Registered date:13/02/2015
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | Functional Dyspepsia |
Date of first enrollment | 13/02/2015 |
Target sample size | 3000 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) | investigational material(s) Generic name etc : Acofide tablets 100mg INN of investigational material : Acotiamide Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : oral |
Outcome(s)
Primary Outcome | Safety rate of side effects |
---|---|
Secondary Outcome | efficacy improvement rate |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | postprandial fullness, upper abdominal bloating, early satiety |
Exclude criteria | malignant disease in upper gastrointestinal tract |
Related Information
Primary Sponsor | ZERIA Pharmaceutical Co.,Ltd. |
---|---|
Secondary Sponsor | Astellas Pharma Inc. |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-152846 |
Contact
Public contact | |
Name | |
Address | iyakujo@zeria.co.jp |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation | ZERIA Pharmaceutical Co.Ltd. & Astellas Pharma Inc. |